Anatara Lifesciences Limited (ASX:ANR) Directors Insider Transactions

The Directors and Chief Executives of Anatara Lifesciences Limited (ASX:ANR) are required by law to report any insider transaction activities i.e. buying, selling, option exercising the Anatara Lifesciences Limited's shares in the stock market. Below table shows the list of insider transactions as reported by Anatara Lifesciences Limited to the ASX stock exchange.

An insider trade occurs when an individual (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. For example, if a number of insiders purchase more shares of a company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.

Anatara Lifesciences Limited Directors/Insider Transactions Activity

List of Insider trades activity from Anatara Lifesciences Limited (ANR).

DateDirectorDirector's TitleSharesValueNote
08 Sep 2021MacLeman (Sue)Non Executive Chairman32,2593,774Purchase at price 0.12 per share.
26 Nov 2020Ramsdale (Tracie Elizabeth)Former4,000--
18 Nov 2020Brookes (David Lionel)Director (Non-Executive)200,00021,900Other at price 0.11 per share.
18 Nov 2020MacLeman (Sue)Non Executive Chairman33,3333,649Other at price 0.11 per share.
18 Nov 2020Ryan (Jane)Director (Non-Executive)133,33314,599Other at price 0.11 per share.
30 Jun 2020Lydeamore (Steven)Chief Executive Officer149,457--
30 Jun 2020West (Michael)Chief Operating Officer82,599--
22 Nov 2019Ramsdale (Tracie Elizabeth)Director (Non-Executive)106,810--
01 Nov 2019Brookes (David Lionel)Director (Non-Executive)50,0006,740Purchase at price 0.13 per share.
01 Nov 2019Ryan (Jane)Director49,7456,531Other at price 0.13 per share.